派博傳思國(guó)際中心

標(biāo)題: Titlebook: Lung Cancer Metastasis; Novel Biological Mec Venkateshwar Keshamouni,Douglas Arenberg,Gregory K Book 2010 Springer-Verlag New York 2010 ang [打印本頁(yè)]

作者: DUCT    時(shí)間: 2025-3-21 16:34
書(shū)目名稱Lung Cancer Metastasis影響因子(影響力)




書(shū)目名稱Lung Cancer Metastasis影響因子(影響力)學(xué)科排名




書(shū)目名稱Lung Cancer Metastasis網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Lung Cancer Metastasis網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Lung Cancer Metastasis被引頻次




書(shū)目名稱Lung Cancer Metastasis被引頻次學(xué)科排名




書(shū)目名稱Lung Cancer Metastasis年度引用




書(shū)目名稱Lung Cancer Metastasis年度引用學(xué)科排名




書(shū)目名稱Lung Cancer Metastasis讀者反饋




書(shū)目名稱Lung Cancer Metastasis讀者反饋學(xué)科排名





作者: Exterior    時(shí)間: 2025-3-21 20:57
Borna Mehrad,Ellen C. Keeley,Robert M. Strieternature of each tissue structure places demands on surgical techniques using lasers and the maximum power parameters used..The predictable application of any laser wavelength currently commercially-available may be viewed as an expression of incident power and the targeting of a predominant chromopho
作者: 祖先    時(shí)間: 2025-3-22 00:24
Mark M. Fuster,Judith A. Varnernature of each tissue structure places demands on surgical techniques using lasers and the maximum power parameters used..The predictable application of any laser wavelength currently commercially-available may be viewed as an expression of incident power and the targeting of a predominant chromopho
作者: Parabola    時(shí)間: 2025-3-22 05:33
Roya Navab Ph.D.,Bizhan Bandarchi M.D.,Ming-Sound Tsaonged very little for over 30?years. The Cochrane Systematic Review from 2000 suggests no obviously superior technique. CO. laser ablation of the vagina is also established as a safe treatment modality for VAIN (Vaginal Intraepithelial Neoplasia), and has been used extensively in the treatment of VIN
作者: Landlocked    時(shí)間: 2025-3-22 09:43
Zvi G. Fridlender,M. Cecilia Crisanti M.D.,Steven M. Albelda M.D.from the Greek ., . ‘light’). The modern accepted definition of phototherapy, however, has become accepted as: “the use of low incident levels of light energy to achieve an athermal and atraumatic, but clinically useful, effect in tissue”. Under its basic original definition, phototherapy is an anci
作者: 令人苦惱    時(shí)間: 2025-3-22 16:13
Jiang Liu,Michael R. Johnston MDfrom the Greek ., . ‘light’). The modern accepted definition of phototherapy, however, has become accepted as: “the use of low incident levels of light energy to achieve an athermal and atraumatic, but clinically useful, effect in tissue”. Under its basic original definition, phototherapy is an anci
作者: membrane    時(shí)間: 2025-3-22 19:12
Mahaveer Swaroop Bhojani,Shyam Nyati,Hyma R. Rao,Brian D. Ross PhD,Alnawaz Rehemtullaver, theoretical models are helpful in planning treatment approaches and laser parameters. In this chapter we discuss basics of lasers, their non laser counterparts, and laser-tissue interactions..Many physicians choose laser settings out of habit (or reading it off of a label attached to the side o
作者: 俗艷    時(shí)間: 2025-3-22 23:53
Gilbert S. Omenn,James D. Cavalcolifrom the Greek ., . ‘light’). The modern accepted definition of phototherapy, however, has become accepted as: “the use of low incident levels of light energy to achieve an athermal and atraumatic, but clinically useful, effect in tissue”. Under its basic original definition, phototherapy is an anci
作者: fibula    時(shí)間: 2025-3-23 04:02

作者: Exhilarate    時(shí)間: 2025-3-23 06:18

作者: 蠟燭    時(shí)間: 2025-3-23 12:55

作者: Resistance    時(shí)間: 2025-3-23 15:26
enetrate deeper than 585 nm and can treat thicker blood vessels. In addition, since the absorption coefficient for melanin is low, epidermal side effects can be reduced (refer to Sect. . in Chap. .) [1]. The pulse duration of Vbeam Perfecta. (Candela Corp. Wayland, MA, USA) can be selected from a to
作者: breadth    時(shí)間: 2025-3-23 21:57
Lung Cancer: Overview,two major histologic subtypes, non-small cell (NSCLC) and small cell (SCLC), with distinct biological behavior, genetic alterations, and therapy. Thus far, screening for lung cancer has not been proven effective since no modality has been shown to decrease mortality. Most patients with both SCLC and
作者: 個(gè)人長(zhǎng)篇演說(shuō)    時(shí)間: 2025-3-24 02:07
Hallmarks of Metastasis,active process requiring genetic and/or epigenetic mechanisms leading to the formation of a cell capable of responding to certain chemotactic signals that direct motility, interacting with other cells to be co-translocated, implanting in foreign locations, avoiding immune response, being refractory
作者: Monocle    時(shí)間: 2025-3-24 03:33

作者: Diastole    時(shí)間: 2025-3-24 06:36
,Epithelial–Mesenchymal Transition as a Mechanism of Metastasis,sto- and organogenesis depend on changes in developmental stage, such as epithelial–mesenchymal transition (EMT), whereby adherent cells disintegrate their intercellular contacts, organize their motility apparatus, and move to new locations in the developing body. EMT generates transitory mesenchyma
作者: vascular    時(shí)間: 2025-3-24 13:14
Mechanisms of Tumor Cell Migration and Invasion in Lung Cancer Metastasis,t of the blood vessels, and accumulation at a distant organ site. These events arise from concomitant alterations in the genetic, chemical, and physical state of tumor cells and its microenvironment. This chapter will, however, focus on the molecular determinants of tumor cell migration and invasion
作者: Facet-Joints    時(shí)間: 2025-3-24 15:31

作者: 留戀    時(shí)間: 2025-3-24 21:55
Angiogenesis and Angiogenic Diversity in Lung Cancer Metastasis,etabolic activity brought on with tissue proliferation . be accompanied by a proportional increase in blood supply. When pre-existing vasculature is insufficient to meet the demands of the proliferating cell population, signals for angiogenesis are generated by resident and infiltrating cells. Angio
作者: 驚惶    時(shí)間: 2025-3-24 23:59

作者: 貝雷帽    時(shí)間: 2025-3-25 06:56
Molecular Control of Lymphatic Metastasis in Lung Cancer, and central component of the lung carcinoma TNM staging system. In recent years, genetic studies in mouse models as well as pathologic human lung cancer studies have revealed a variety of molecules that may critically regulate thoracic lymph node metastasis. These include important lymphatic endoth
作者: Ligament    時(shí)間: 2025-3-25 09:55
Carcinoma-Associated Fibroblasts in Lung Cancer,s. Therefore, the stromal cells surrounding cancer epithelial cells, rather than being passive bystanders, appear to have an important role in modifying tumor development and progression. Clinical evidence also supports the significant contribution of stroma to the development of a wide variety of t
作者: 虛度    時(shí)間: 2025-3-25 12:15
The Role of Tumor-Associated Macrophages and Other Innate Immune Cells in Metastatic Progression ofspread. Given that macrophages are the most frequent hematopoietic cells found in the tumor microenvironment, they play an especially important part in tumor biology. There are numerous mechanisms by which tumor-associated innate immune cells can influence most aspects of the metastatic process. The
作者: 可商量    時(shí)間: 2025-3-25 17:29

作者: OTHER    時(shí)間: 2025-3-25 20:12
Molecular Imaging in Lung Cancer Metastases, cancer and the spread of malignancy to distant organs. Molecular imaging is a very promising technology which provides the potential for utilizing these biomarkers for monitoring tumor progression and therapeutic response. This technology may allow real-time, dynamic, and quantifiable monitoring of
作者: EXCEL    時(shí)間: 2025-3-26 03:32
Biomarker Discovery for Metastatic Disease,markers and targets for therapy. A systems biology approach that encompasses differential expression of mRNAs (gene expression), microRNAs (gene regulators), and proteins in primary and metastatic tumors, in proximal biofluids, and in the blood plasma generates potentially complementary molecular si
作者: oxidant    時(shí)間: 2025-3-26 07:40

作者: FILLY    時(shí)間: 2025-3-26 09:47
Site-Directed Therapy for Lung Cancer Metastases,dvanced metastatic disease. The prognosis of patients with advanced lung cancer is dismal, with a 5-year overall survival rate of 1–2%. The primary treatment of advanced disease is supportive care and palliative chemotherapy. However, there is a growing body of evidence suggesting that highly select
作者: CHOIR    時(shí)間: 2025-3-26 15:11

作者: preeclampsia    時(shí)間: 2025-3-26 19:33
Venkateshwar Keshamouni,Douglas Arenberg,Gregory KWill provide important insights into current research in this area.The area of lung cancer metastasis is a very timely subject in view that lung cancer remains the number 1 cause of cancer death in bo
作者: 我還要背著他    時(shí)間: 2025-3-26 21:56
http://image.papertrans.cn/l/image/589075.jpg
作者: Ascendancy    時(shí)間: 2025-3-27 04:37

作者: pessimism    時(shí)間: 2025-3-27 05:45
Chemokines in Lung Cancer Metastasis,biological processes, including control of cancer angiogenesis and mediating homing of metastatic cells. In this chapter, we review the role of chemokines in angiogenesis and angiostasis and metastasis in the context of lung cancer.
作者: 花爭(zhēng)吵    時(shí)間: 2025-3-27 09:31

作者: 組裝    時(shí)間: 2025-3-27 14:46
Tumor Stem Cells and Metastasis, of lung cancer. This chapter will discuss the emerging data supporting the validity of this notion and consider the growing evidence that cancer stem cells may contribute to tumor progression, drug resistance, metastasis, and speculates about how taking these cells into consideration may affect the way we treat lung cancer in the future.
作者: 小丑    時(shí)間: 2025-3-27 19:30
Angiogenesis and Angiogenic Diversity in Lung Cancer Metastasis,gnature of each tumor’s microenvironment [7, 8]. This chapter will focus on the basic cellular mechanisms of angiogenesis, followed by a discussion of various factors that are involved in lung cancer angiogenesis, and the clinical implications of the diversity of angiogenic pathways in cancer.
作者: 相一致    時(shí)間: 2025-3-28 01:29
Book 2010ed deaths. However, relatively little progress has been made in understanding the process of lung cancer metastasis. The two main aims of this book are a) to introduce clinical aspects to basic scientists and basic molecular and cellular concepts to clinical investigators, in order to promote collab
作者: Fantasy    時(shí)間: 2025-3-28 02:05
Biomarker Discovery for Metastatic Disease,ators), and proteins in primary and metastatic tumors, in proximal biofluids, and in the blood plasma generates potentially complementary molecular signatures. We illustrate the use of Oncomine and Molecular Concepts Maps and the biological amplification of tumor protein signals with immune .
作者: inventory    時(shí)間: 2025-3-28 10:06
Hallmarks of Metastasis,tates a detailed understanding of the molecular and cellular mechanisms behind each of these steps. In this chapter, we will discuss hallmarks of metastatic process, along with theories proposed, genes involved, techniques to monitor, and therapeutic implications.
作者: macrophage    時(shí)間: 2025-3-28 11:03

作者: 凝結(jié)劑    時(shí)間: 2025-3-28 17:12

作者: 現(xiàn)任者    時(shí)間: 2025-3-28 21:21

作者: annexation    時(shí)間: 2025-3-29 00:46

作者: 戰(zhàn)役    時(shí)間: 2025-3-29 04:25

作者: 夾克怕包裹    時(shí)間: 2025-3-29 07:55

作者: formula    時(shí)間: 2025-3-29 12:49
nto the mechanisms of metastasis. Some of the subjects covered will include: defining basic hallmarks of a metastatic cell, the concept of tumor stem cells, epithelial-mesenchymal transitions, evasion of immune-surveillance, tumor-stromal interactions, angiogenesis, molecular imaging and biomarker discovery..978-1-4899-8111-0978-1-4419-0772-1
作者: relieve    時(shí)間: 2025-3-29 16:29

作者: 言外之意    時(shí)間: 2025-3-29 20:57

作者: 晚來(lái)的提名    時(shí)間: 2025-3-30 00:23
Douglas A. Arenbergeodymium YAG (1.064?μm) which was launched in 1989. From there the next 5?years witnessed the emergence of other major wavelengths, notably the two Erbium wavelengths (Er:YAG and Er,Cr:YSGG) and Diode group of semiconductor based technology. Latterly, the most recent 5–10?years has seen an emergence
作者: 案發(fā)地點(diǎn)    時(shí)間: 2025-3-30 08:03

作者: Merited    時(shí)間: 2025-3-30 09:55
Mark M. Fuster,Judith A. Varnereodymium YAG (1.064?μm) which was launched in 1989. From there the next 5?years witnessed the emergence of other major wavelengths, notably the two Erbium wavelengths (Er:YAG and Er,Cr:YSGG) and Diode group of semiconductor based technology. Latterly, the most recent 5–10?years has seen an emergence
作者: 藕床生厭倦    時(shí)間: 2025-3-30 14:53

作者: sacrum    時(shí)間: 2025-3-30 19:41

作者: aneurysm    時(shí)間: 2025-3-30 22:23
Jiang Liu,Michael R. Johnston MDitizing properties of the parsley caused an intense photoreaction in the skin leading to a very nasty sunburn, which in turn hopefully led to the appearance of postinflammatory secondary hyperpigmentation, or ‘suntan’ thereby repigmenting the depigmented area. In their turn the Ancient Greeks and Ro
作者: 曲解    時(shí)間: 2025-3-31 02:52
Mahaveer Swaroop Bhojani,Shyam Nyati,Hyma R. Rao,Brian D. Ross PhD,Alnawaz Rehemtulla of the light-tissue interaction. However, a comprehension of first principles allows for a logical analysis of final clinical outcomes—furthermore, more creative uses of equipment should follow. For example, with an education in laser tissue interactions (LTIs) and tissue cooling, one can deploy th
作者: Pastry    時(shí)間: 2025-3-31 05:06

作者: 小丑    時(shí)間: 2025-3-31 10:48
Bryan J. Schneider MD,Suresh S. Ramalingam MDncrease safety (refer to Sect. . in Chap. .). Spray duration is the time during which DCD is sprayed before laser irradiation, and spray delay duration is the non-irradiation time between spray and laser irradiation. Therefore, the longer the spray duration and the shorter the spray delay duration,




歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
渝中区| 神木县| 龙陵县| 通河县| 舒兰市| 赫章县| 宁河县| 海盐县| 新绛县| 亳州市| 昌邑市| 甘孜县| SHOW| 绥棱县| 扶余县| 吉安县| 南澳县| 湖北省| 五大连池市| 金门县| 保定市| 宾阳县| 杨浦区| 昌吉市| 洞口县| 故城县| 铜梁县| 乌拉特前旗| 察哈| 铅山县| 璧山县| 岐山县| 绥滨县| 繁昌县| 竹溪县| 罗源县| 南阳市| 闵行区| 杭州市| 汉沽区| 祁门县|